Elixirr International (LON:ELIX) Insider Acquires £2,523 in Stock

Key Points

• Insider Nick Willott of Elixirr International acquired 300 shares at an average price of GBX 841, totaling £2,523.
• Elixirr International's stock is currently priced at GBX 838, with a market cap of £399.76 million and a high P/E ratio of 2,648.55.
• The company reported a 31.70 GBX EPS for the last quarter, with an expected annual EPS of 44.52 according to analysts.

Elixirr International plc (LON:ELIX - Get Free Report) insider Nick Willott acquired 300 shares of the stock in a transaction dated Wednesday, September 24th. The stock was acquired at an average cost of GBX 841 per share, with a total value of £2,523.

Elixirr International Price Performance

Shares of LON:ELIX opened at GBX 838 on Thursday. The company has a market cap of £399.76 million, a P/E ratio of 2,648.55 and a beta of 0.63. The company has a quick ratio of 1.29, a current ratio of 1.51 and a debt-to-equity ratio of 3.90. Elixirr International plc has a 52 week low of GBX 560 and a 52 week high of GBX 880. The business has a fifty day simple moving average of GBX 731.51 and a 200-day simple moving average of GBX 724.02.

Elixirr International (LON:ELIX - Get Free Report) last announced its quarterly earnings data on Monday, September 22nd. The company reported GBX 31.70 EPS for the quarter. Elixirr International had a return on equity of 15.21% and a net margin of 18.83%. Equities research analysts forecast that Elixirr International plc will post 44.516129 EPS for the current year.

About Elixirr International

Elixirr is a global consulting firm with a bold ambition: to become the best consulting firm in the world. Founded in 2009 to challenge a declining industry standard, we've grown from a single vision into a powerhouse of entrepreneurial talent. We partner with businesses around the world to deliver transformational results, from boardroom strategy through to execution, powered by the technology of tomorrow.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.